Home › Disturbo depressivo maggiore › California
Studi clinici su Disturbo depressivo maggiore nello stato di California
52 studi su Disturbo depressivo maggiore cercano partecipanti presso sedi nello stato di California.
Città nello stato di California
- San Diego16 studi
- Orange13 studi
- Glendale12 studi
- Los Angeles12 studi
- Concord12 studi
- Oceanside9 studi
- San Bernardino8 studi
- San Francisco8 studi
- San Jose7 studi
- Mountain View7 studi
- Chino6 studi
- Bellflower6 studi
- Garden Grove4 studi
- Santa Monica4 studi
- Long Beach4 studi
- Burbank4 studi
- Anaheim3 studi
- Mission Viejo3 studi
- Downey3 studi
- Irvine3 studi
Testo ufficiale dello studio (inglese)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Oakland Clinical, Oakland
- e altri 1
In reclutamentoFase 3
Età da 18 a 75 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- CI Trials, Bellflower
- Behavioral Research Specialists LLC, Glendale
- Excell Research Inc, Oceanside
- e altri 3
In reclutamentoFase 3
Età da 18 a 74 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- PAMOJA Clinical Institute LLC, Anaheim
- Axiom Research, Colton
- Behavioral Research Specialists LLC, Glendale
- e altri 3
In reclutamentoFase 3
Età da 18 a 74 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Buena Park Research Center, Buena Park
- Inland Psychiatric Medical Group, Inc. - Chino, Chino
- Synergy Research - San Diego, Lemon Grove
- e altri 3
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- CNRI-Los Angeles, LLC, Pico Rivera
In reclutamentoFase 3
Età da 18 a 65 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Behavioral Research Specialists, LLC, Glendale
- CalNeuro Research Group, Los Angeles
- Lipov Medical Group, Los Angeles
- e altri 4
In reclutamentoFase 3
Età da 18 a 85 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Garden Grove
- Vanda Investigational Site, Orange
- Vanda Investigational Site, Redlands
- e altri 2
In reclutamentoFase 3
Età da 18 a 65 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Fresno
- Neurocrine Clinical Site, Long Beach
- e altri 3
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT07105111Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
- UCSD Interventional Psychiatry, San Diego
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07217223A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Chino
- Seaport Investigator Site, Garden Grove
- Seaport Investigator Site, Glendale
- e altri 2
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Inland Psychiatric Medical Group, Chino
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- e altri 1
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07284667Near Infrared Spectroscopy (NIRS) for Assessment of Depression
- San Francisco Veterans Affairs Medical Center, San Francisco
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT04061148A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Clinical Innovations Inc, Bellflower
- Center for Neurohealth, La Jolla
- Artemis Institute for Clinical Research, San Diego
- e altri 1
In reclutamentoFase 3
Età da 18 a 74 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellflower
- Draig Clinical Site, Costa Mesa
- Draig Clinical Site, Lafayette
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USC University Hospital, Los Angeles
- UCLA Department of Psychiatry, Los Angeles
- University of California at Davis, Sacramento
In reclutamento
Età da 22 a 70 · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Oceanside
- Draig Clinical Site, San Diego
- Draig Clinical Site, Torrance
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT07300969Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
- Stanford University, Stanford
In reclutamento
Età 65 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT07188623Enhancing Veteran-Clinical Collaboration in VA PRRCs
- VA San Diego Healthcare System, San Diego, CA, San Diego
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT06898879NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glendale
- Neurocrine Clinical Site, Redlands
- Neurocrine Clinical Site, San Francisco
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06911112Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
- Stanford Hospital, Stanford
In reclutamento
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT04870255Pain and Major Depressive Disorder
- UCLA Semel Institute, Los Angeles
In reclutamentoIndica un rimborso per i partecipanti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT04556890A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- ATP Clinical Research Orange County, Orange
- Kadima Neuropsychiatry Institute, San Diego
- UCSF Department of Neurology, San Francisco
- e altri 1
In reclutamentoFase 3
Età da 18 a 74 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Los Angeles
- Neurocrine Clinical Site, Stanford
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Accellacare - Moorpark, Moorpark
- ATP Clinical Research, Orange
In reclutamentoFase 3
Età da 18 a 75 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT07412756Closed-Loop Deep Brain Stimulation for Major Depression
- University of California, San Francisco, San Francisco
In reclutamento
Età da 22 a 70 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT04004169A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Behavioral Research Specialists, Llc, Glendale
- Irvine Clinical Research, Irvine
- CalNeuro Research Group, Inc., Los Angeles
- e altri 6
In reclutamentoFase 3
Età da 18 a 74 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Irvine Clinical Research, Irvine
- CalNeuro Research Group, Los Angeles
- Sunwise Clinical Research LLC, Walnut Creek
In reclutamentoFase 2
Età da 18 a 64 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Catalina Research Institute, LLC, Montclair
- Excell Research, Inc, Oceanside
- Anderson Clinical Research, Redlands
- e altri 3
In reclutamentoFase 2
Età da 18 a 64 · Tutti i sessi · Aggiornato il 27 lug 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Oceanside
- Neurocrine Clinical Site, Orange
- Neurocrine Clinical Site, San Jose
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 lug 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glendale
- Neurocrine Clinical Site, Los Angeles
- Neurocrine Clinical Site, Oceanside
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 lug 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Bellflower
- Clinical Research Site, Chino
- Clinical Research Site, Glendale
- e altri 7
In reclutamentoFase 3
Età da 18 a 65 · Tutti i sessi · Aggiornato il 24 lug 2026 · NCT07484217Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Acacia Clinics, Sunnyvale
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 16 lug 2026 · NCT06376734Sleep TMS for Depression
- Stanford University, Stanford
In reclutamentoVolontari sani benvenuti
Età da 18 a 65 · Tutti i sessi · Aggiornato il 23 giu 2026 · NCT06824415A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Advanced Research Center /ID# 277537, Anaheim
- Sun Valley Research Center /ID# 277513, Imperial
- Synergy San Diego /ID# 277553, Lemon Grove
- e altri 4
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 15 giu 2026 · NCT07276997Evaluating tDCS Brain-stimulation in Depression Using MRI
- University of California Los Angeles (UCLA), Los Angeles
In reclutamento
Età da 20 a 55 · Tutti i sessi · Aggiornato il 8 giu 2026 · NCT05598034A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Garden Grove
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- e altri 2
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 11 mag 2026 · NCT06524830Mindfulness Engaged Neurostimulation for Depression (MEND II)
- UC San Diego Health Psychiatry, San Diego
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 6 mag 2026 · NCT07512284Regulation of Affect and Physiology in Depression
- University of Southern California, Los Angeles
In reclutamentoFase 2Volontari sani benvenuti
Età da 18 a 27 · Tutti i sessi · Aggiornato il 4 mag 2026 · NCT06345859Maintenance rTMS for Depression (Maitr-De)
- University of California, San Diego, San Diego
In reclutamento
Età da 18 a 80 · Tutti i sessi · Aggiornato il 29 apr 2026 · NCT06938841ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
- Salma Health, La Jolla
- Salma Health, Laguna Hills
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 apr 2026 · NCT07528014Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.